LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Acute-onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro-pollutants.

    Schneider, Francis / Agin, Arnaud / Baldacini, Mathieu / Maurer, Loïc / Schenck, Maleka / Alemann, Mathieu / Solis, Morgane / Helms, Julie / Villette, Claire / Artzner, Thierry / Kremer, Stéphane / Heintz, Dimitri

    European journal of neurology

    2021  Volume 28, Issue 10, Page(s) 3443–3447

    Abstract: Background and purpose: COVID-19 affects the brain in various ways, amongst which delirium is worrying. An assessment was made of whether a specific, long-lasting, COVID-19-related brain injury develops in acute respiratory distress syndrome patients ... ...

    Abstract Background and purpose: COVID-19 affects the brain in various ways, amongst which delirium is worrying. An assessment was made of whether a specific, long-lasting, COVID-19-related brain injury develops in acute respiratory distress syndrome patients after life-saving re-oxygenation.
    Methods: Ten COVID+ patients (COVID+) with unusual delirium associated with neuroimaging suggestive of diffuse brain injury and seven controls with non-COVID encephalopathy were studied. The assessment took place when the intractable delirium started at weaning off ventilation support. Brain magnetic resonance imaging (MRI) was performed followed by standard cerebrospinal fluid (CSF) analyses and assessment of CSF erythropoietin concentrations (as a marker for the assessment of tissue repair), and of non-targeted CSF metabolomics using liquid chromatography high resolution mass spectrometry.
    Results: Patients were similar as regards severity scores, but COVID+ were hospitalized longer (25 [11.75; 25] vs. 9 [4.5; 12.5] days, p = 0.03). On admission, but not at MRI and lumbar puncture performance, COVID+ were more hypoxic (p = 0.002). On MRI, there were leptomeningeal enhancement and diffuse white matter haemorrhages only in COVID+. In the latter, CSF erythropoietin concentration was lower (1.73 [1.6; 2.06] vs. 3.04 [2.9; 3.91] mIU/ml, p = 0.01), and CSF metabolomics indicated (a) increased compounds such as foodborne molecules (sesquiterpenes), molecules from industrialized beverages and micro-pollutants (diethanolamine); and (b) decreased molecules such as incomplete breakdown products of protein catabolism and foodborne molecules (glabridin). At 3-month discharge, fatigue, anxiety and depression as well as MRI lesions persisted in COVID+.
    Conclusions: Some COVID+ are at risk of a specific delirium. Imperfect brain repair after re-oxygenation and lifestyle factors might influence long-lasting brain injuries in a context of foodborne micro-pollutants.
    MeSH term(s) Brain/diagnostic imaging ; COVID-19 ; Critical Care ; Delirium ; Environmental Pollutants ; Humans ; SARS-CoV-2
    Chemical Substances Environmental Pollutants
    Language English
    Publishing date 2021-03-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 1280785-0
    ISSN 1468-1331 ; 1351-5101 ; 1471-0552
    ISSN (online) 1468-1331
    ISSN 1351-5101 ; 1471-0552
    DOI 10.1111/ene.14776
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia.

    Baldacini, Mathieu / Pop, Raoul / Sattler, Laurent / Mauvieux, Laurent / Bilger, Karin / Gantzer, Justine / Schneider, Francis / Beaujeux, Remy / Simand, Célestine / Herbrecht, Raoul

    British journal of haematology

    2020  Volume 189, Issue 6, Page(s) 1054–1056

    MeSH term(s) Arterial Occlusive Diseases/blood ; Arterial Occlusive Diseases/diagnostic imaging ; Arterial Occlusive Diseases/etiology ; Arterial Occlusive Diseases/therapy ; Betacoronavirus ; COVID-19 ; Computed Tomography Angiography ; Coronavirus Infections/blood ; Coronavirus Infections/diagnostic imaging ; Coronavirus Infections/etiology ; Coronavirus Infections/therapy ; Fatal Outcome ; Female ; Hemorrhage/blood ; Hemorrhage/diagnostic imaging ; Hemorrhage/etiology ; Hemorrhage/therapy ; Humans ; Leukemia, Promyelocytic, Acute/blood ; Leukemia, Promyelocytic, Acute/complications ; Leukemia, Promyelocytic, Acute/diagnostic imaging ; Leukemia, Promyelocytic, Acute/therapy ; Middle Aged ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/diagnostic imaging ; Pneumonia, Viral/etiology ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Syndrome ; Thrombosis/blood ; Thrombosis/diagnostic imaging ; Thrombosis/etiology
    Keywords covid19
    Language English
    Publishing date 2020-05-26
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.16768
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study.

    Helms, Julie / Severac, François / Merdji, Hamid / Schenck, Maleka / Clere-Jehl, Raphaël / Baldacini, Mathieu / Ohana, Mickaël / Grunebaum, Lélia / Castelain, Vincent / Anglés-Cano, Eduardo / Sattler, Laurent / Meziani, Ferhat

    Annals of intensive care

    2021  Volume 11, Issue 1, Page(s) 14

    Abstract: Background: Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or ... ...

    Abstract Background: Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage of heparin. All patients referred for COVID-19 ARDS in two intensive care units (ICUs) from two centers of a French tertiary hospital were included in our cohort study. Patients were compared according to their anticoagulant treatment to evaluate the risk/benefit of prophylactic anticoagulation versus therapeutic anticoagulation. Medical history, symptoms, biological data and imaging were prospectively collected.
    Results: One hundred and seventy-nine patients (73% men) were analyzed: 108 in prophylactic group and 71 in therapeutic group. Median age and SAPS II were 62 [IQR 51; 70] years and 47 [IQR 37; 63] points. ICU mortality rate was 17.3%. Fifty-seven patients developed clinically relevant thrombotic complications during their ICU stay, less frequently in therapeutic group (adjusted OR 0.38 [0.14-0.94], p = 0.04). The occurrences of pulmonary embolism (PE), deep vein thrombosis (DVT) and ischemic stroke were significantly lower in the therapeutic group (respective adjusted OR for PE: 0.19 [0.03-0.81]; DVT: 0.13 [0.01-0.89], stroke: 0.06 [0-0.68], all p < 0.05). The occurrence of bleeding complications was not significantly different between groups, neither were ICU length of stay or mortality rate. D-dimer levels were significantly lower during ICU stay, and aPTT ratio was more prolonged in the therapeutic group (p < 0.05).
    Conclusion: Increasing the anticoagulation of severe COVID-19 patients to a therapeutic level might decrease thrombotic complications without increasing their bleeding risk.
    Language English
    Publishing date 2021-01-25
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2617094-2
    ISSN 2110-5820
    ISSN 2110-5820
    DOI 10.1186/s13613-021-00809-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia

    Baldacini, Mathieu / Pop, Raoul / Sattler, Laurent / Mauvieux, Laurent / Bilger, Karin / Gantzer, Justine / Schneider, Francis / Beaujeux, Remy / Simand, Célestine / Herbrecht, Raoul

    Br J Haematol

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #186650
    Database COVID19

    Kategorien

  5. Article ; Online: Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia

    Baldacini, Mathieu / Pop, Raoul / Sattler, Laurent / Mauvieux, Laurent / Bilger, Karin / Gantzer, Justine / Schneider, Francis / Beaujeux, Remy / Simand, Célestine / Herbrecht, Raoul

    British Journal of Haematology

    2020  Volume 189, Issue 6, Page(s) 1054–1056

    Keywords Hematology ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.16768
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007-2020.

    Kaeuffer, Charlotte / Baldacini, Mathieu / Ruge, Tiffany / Ruch, Yvon / Zhu, Yves-Jean / De Cian, Manon / Philouze, Guillaume / Bachellier, Philippe / Denis, Julie / Lefebvre, Nicolas / Schneider, Francis / Hansmann, Yves / Letscher-Bru, Valérie / Herbrecht, Raoul / Sabou, Marcela / Danion, François

    Emerging infectious diseases

    2021  Volume 28, Issue 1, Page(s) 29–34

    Abstract: Rare fungal pathogens are emerging as agents of invasive fungal infections. We analyzed 13 cases of fungal infections caused by Kazachstania (Arxiozyma) spp. in Strasbourg University Hospital, Strasbourg, France. Among the cases, 4 patients had proven ... ...

    Abstract Rare fungal pathogens are emerging as agents of invasive fungal infections. We analyzed 13 cases of fungal infections caused by Kazachstania (Arxiozyma) spp. in Strasbourg University Hospital, Strasbourg, France. Among the cases, 4 patients had proven fungal disease (3 cases of invasive fungal disease and 1 mucocutaneous infection) and 9 were colonized by Kazachstania (Arxiozyma) spp. Candida albicans was also isolated from 11 of the 13 patients. None of the patients with proven invasive fungal disease met host criteria, but most had underlying diseases. All strains were identified as K. telluris by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and 3 were confirmed as K. bovina by internal transcribed spacer sequencing. For all tested strains, the MICs for fluconazole were >2 μg/mL. Emergence of this rare fungal infection might be explained by the increasing number of patients with immunocompromised conditions and gastroesophageal diseases.
    MeSH term(s) Antifungal Agents/pharmacology ; Antifungal Agents/therapeutic use ; Fluconazole ; Humans ; Microbial Sensitivity Tests ; Mycoses/epidemiology ; Saccharomycetales ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
    Chemical Substances Antifungal Agents ; Fluconazole (8VZV102JFY)
    Language English
    Publishing date 2021-12-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid2801.211543
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial.

    Labro, Guylaine / Tubach, Florence / Belin, Lisa / Dubost, Jean-Louis / Osman, David / Muller, Grégoire / Quenot, Jean-Pierre / Da Silva, Daniel / Zarka, Jonathan / Turpin, Matthieu / Mayaux, Julien / Lamer, Christian / Doyen, Denis / Chevrel, Guillaume / Plantefeve, Gaétan / Demeret, Sophie / Piton, Gaël / Manzon, Cyril / Ochin, Evelina /
    Gaillard, Raphael / Dautzenberg, Bertrand / Baldacini, Mathieu / Lebbah, Said / Miyara, Makoto / Pineton de Chambrun, Marc / Amoura, Zahir / Combes, Alain

    Intensive care medicine

    2022  Volume 48, Issue 7, Page(s) 876–887

    Abstract: Purpose: Epidemiologic studies have documented lower rates of active smokers compared to former or non-smokers in symptomatic patients affected by coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of nicotine administered by a ... ...

    Abstract Purpose: Epidemiologic studies have documented lower rates of active smokers compared to former or non-smokers in symptomatic patients affected by coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of nicotine administered by a transdermal patch in critically ill patients with COVID-19 pneumonia.
    Methods: In this multicentre, double-blind, placebo-controlled trial conducted in 18 intensive care units in France, we randomly assigned adult patients (non-smokers, non-vapers or who had quit smoking/vaping for at least 12 months) with proven COVID-19 pneumonia receiving invasive mechanical ventilation for up to 72 h to receive transdermal patches containing either nicotine at a daily dose of 14 mg or placebo until 48 h following successful weaning from mechanical ventilation or for a maximum of 30 days, followed by 3-week dose tapering by 3.5 mg per week. Randomization was stratified by centre, non- or former smoker status and Sequential Organ Function Assessment score (< or ≥ 7). The primary outcome was day-28 mortality. Main prespecified secondary outcomes included 60-day mortality, time to successful extubation, days alive and free from mechanical ventilation, renal replacement therapy, vasopressor support or organ failure at day 28.
    Results: Between November 6th 2020, and April 2nd 2021, 220 patients were randomized from 18 active recruiting centers. After excluding 2 patients who withdrew consent, 218 patients (152 [70%] men) were included in the analysis: 106 patients to the nicotine group and 112 to the placebo group. Day-28 mortality did not differ between the two groups (30 [28%] of 106 patients in the nicotine group vs 31 [28%] of 112 patients in the placebo group; odds ratio 1.03 [95% confidence interval, CI 0.57-1.87]; p = 0.46). The median number of day-28 ventilator-free days was 0 (IQR 0-14) in the nicotine group and 0 (0-13) in the placebo group (with a difference estimate between the medians of 0 [95% CI -3-7]). Adverse events likely related to nicotine were rare (3%) and similar between the two groups.
    Conclusion: In patients having developed severe COVID-19 pneumonia requiring invasive mechanical ventilation, transdermal nicotine did not significantly reduce day-28 mortality. There is no indication to use nicotine in this situation.
    MeSH term(s) Adult ; COVID-19/therapy ; Double-Blind Method ; Female ; Humans ; Intensive Care Units ; Male ; Nicotine/adverse effects ; Respiration, Artificial ; SARS-CoV-2 ; Treatment Outcome
    Chemical Substances Nicotine (6M3C89ZY6R)
    Language English
    Publishing date 2022-06-09
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 80387-x
    ISSN 1432-1238 ; 0340-0964 ; 0342-4642 ; 0935-1701
    ISSN (online) 1432-1238
    ISSN 0340-0964 ; 0342-4642 ; 0935-1701
    DOI 10.1007/s00134-022-06721-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top